SCB-1019 - Sichuan Clover Biopharma
Arexvy (respiratory syncytial virus vaccine, adjuvanted) - GSK
A Novel Unadjuvanted Subunit Respiratory Syncytial Virus Prefusion F Vaccine Induces Potent and Differentiated Functional Immune Responses Compared to AS01-Adjuvanted Arexvy in Older Adults. (PubMed, Open Forum Infect Dis) - Jan 14, 2026 - "The humoral immunogenicity SCB-1019T was similar to that of Arexvy, which contains the potent AS01E adjuvant. Therefore, this phase 1 study supports further development of SCB-1019T, notably in heterologous booster settings." 
Journal • Respiratory Diseases • Respiratory Syncytial Virus Infections
http://www.ncbi.nlm.nih.gov/pubmed/41531504
 
Ana Sun; Christopher Rook; Donna Ambrosino; George Siber; Joshua G Liang; Nicholas Jackson; Nicolas Burdin; Peter Richmond; Ralf Clemens; Sue Ann Costa-Clemens; Terence T L Kwan; Wei Tan
 
Jan 14, 2026
 
Prev Next